NCT02145247View on ClinicalTrials.gov

Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

January 31, 2018

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

hCG

"3\. On study day one, recombinant-hCG (r-hCG) will be administered intravenously at a dose of 25 micrograms.~4\. Blood samples will be obtained at T = -0.5, 0, and +24 hours."

Trial Locations (1)

92037

University of California, San Diego, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02145247 - Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter